Related Experiment Video
Updated: Nov 22, 2025

08:37
Polarization and Characterization of M1 and M2 Human Monocyte-Derived Macrophages on Implant Surfaces
Published on: December 6, 2024
1.3K
Macrophage Polarization by Titanium Dioxide (TiO2) Particles: Size Matters
Angelina D Schoenenberger1,2, Angela Schipanski, Vera Malheiro
1Department of Orthopaedics, Balgrist Hospital, University of Zurich, Zurich, Switzerland.
ACS Biomaterials Science & Engineering
|January 12, 2021
Summary
Particle size significantly influences macrophage response in total joint replacements. Microsized titanium dioxide particles promote inflammation, while nanoparticles do not, guiding future biomaterial design.
Area of Science:
- Biomaterials Science
- Immunology
- Cell Biology
Background:
- Wear particles from total joint replacements can trigger inflammatory responses via monocyte/macrophage lineage cells.
- Continuous particle release is linked to periprosthetic osteolysis and aseptic loosening of implants.
Purpose of the Study:
- To investigate how differently sized titanium dioxide (TiO2) particles influence macrophage polarization.
- To determine if nano- or micro-sized TiO2 particles induce M1 (pro-inflammatory) or M2-like (anti-inflammatory) phenotypes in macrophages.
Main Methods:
- Utilized an in vitro model with THP-1 monocytes exposed to varying concentrations of nano- and micro-sized TiO2 particles.
- Assessed macrophage polarization by quantifying gene expression (qRT-PCR) of key markers and measuring protein levels (ELISA).
Main Results:
- Microsized TiO2 particles, at high concentrations, significantly elevated pro-inflammatory markers (TNF-α, CD197) at both gene and protein levels.
- No significant M2-like phenotype markers (CCL22, CD206) were observed.
- Nanoparticle exposure did not induce polarization towards either M1 or M2-like phenotypes at any concentration.
Conclusions:
- Particle size is a critical determinant of macrophage biological response.
- Understanding this size-dependent response may inform the development of safer, next-generation biomaterials for joint replacements.

